Aquestive Therapeutics Inc. (AQST)
4.81
-0.07 (1.43%)
Upcoming Events
Latest Headlines
Form 144 Aquestive Therapeutics, Filed by: Barber Daniel
September 15, 2026 4:49 PM - SEC Filing
Form 4 Aquestive Therapeutics, For: Sep 09 Filed by: Korczynski Sherry
September 11, 2026 11:08 AM - SEC Filing
Cantor Fitzgerald Reiterates Overweight Rating on Aquestive Therapeutics (AQST)
September 10, 2026 9:31 AM - StreetInsider
Form 4 Aquestive Therapeutics, For: Sep 09 Filed by: Boyd Peter E.
September 10, 2026 9:22 AM - SEC Filing
Aquestive Therapeutics to Participate in Upcoming September Investor Conferences
September 1, 2026 7:00 AM - StreetInsider
Form 4 Aquestive Therapeutics, For: Aug 17 Filed by: Barber Daniel
August 18, 2026 4:13 PM - SEC Filing
Form 4 Aquestive Therapeutics, For: Aug 14 Filed by: Korczynski Sherry
August 17, 2026 5:34 PM - SEC Filing
Form 144 Aquestive Therapeutics, Filed by: Barber Daniel
August 17, 2026 4:35 PM - SEC Filing
Form 10-Q Aquestive Therapeutics, For: Jun 30
August 11, 2026 4:12 PM - SEC Filing
Form 8-K Aquestive Therapeutics, For: Aug 11
August 11, 2026 4:07 PM - SEC Filing
Aquestive Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
August 11, 2026 4:01 PM - Globe NewsWire
Aquestive Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
August 11, 2026 4:01 PM - StreetInsider
Form 8-K Aquestive Therapeutics, For: Aug 10
August 10, 2026 7:06 AM - SEC Filing
Aquestive reports study results for Anaphylm ahead of NDA resubmission
August 10, 2026 7:02 AM - StreetInsider
Aquestive Therapeutics Announces Positive Topline Human Factors and Pharmacokinetic Study Results for Anaphylm™ (dibutepinephrine) Sublingual Film
August 10, 2026 7:00 AM - StreetInsider
Aquestive Therapeutics to Report Second Quarter 2026 Financial Results and Recent Business Highlights on August 11 and Host Conference Call on August 12 at 8:00 a.m. ET
July 29, 2026 7:00 AM - StreetInsider
Form SCHEDULE 13G/A Aquestive Therapeutics, Filed by: BlackRock, Inc.
July 27, 2026 4:26 PM - SEC Filing
Form 4 Aquestive Therapeutics, For: Jul 15 Filed by: Barber Daniel
July 17, 2026 1:15 PM - SEC Filing
Form 144 Aquestive Therapeutics, Filed by: Barber Daniel
July 15, 2026 4:38 PM - SEC Filing
Form 424B3 Aquestive Therapeutics,
July 9, 2026 4:30 PM - SEC Filing
Form EFFECT Aquestive Therapeutics,
July 9, 2026 6:03 AM - SEC Filing
Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism
July 7, 2026 7:00 AM - Globe NewsWire
Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism
July 7, 2026 7:00 AM - StreetInsider
Form S-3 Aquestive Therapeutics,
June 26, 2026 4:21 PM - SEC Filing
Form 4 Aquestive Therapeutics, For: Jun 23 Filed by: Krop Julie
June 24, 2026 11:11 AM - SEC Filing
Form 144 Aquestive Therapeutics, Filed by: Krop Julie
June 23, 2026 4:27 PM - SEC Filing
Full Article List
